Medicare Enrolled

Dr. Seth Hollander, M.D.

Internal Medicine · Austin, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
5625 EIGER RD STE 160, Austin, TX 78735
5127322774
In practice since 2007 (19 years)
NPI: 1255451886 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hollander from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hollander? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hollander

Dr. Seth Hollander is an internal medicine in Austin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Hollander performed 11,123 Medicare services across 536 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hollander received a total of $13,108 from 43 pharmaceutical and/or device companies across 573 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hollander is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 3% volume in TX$ $13,108 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,123
Medicare services
Top 3% in TX for internal medicine
536
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~585 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Inclisiran injection (Leqvio) for cholesterol5,396$9$34
Allergy immunotherapy preparation2,515$12$20
Allergy skin test2,005$3$9
Allergy injection therapy, multiple injections752$8$25
Office visit, established patient (30-39 min)120$90$169
Office visit, established patient (20-29 min)76$61$114
Remote patient monitoring management, 20 min/month63$38$105
Drug injection, under skin or into muscle59$10$53
Test to measure rate of airflow57$29$55
Professional service for single injection of allergen43$7$20
New patient office visit (45-59 min)37$116$245
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,108
Total received (2018-2024)
Avg $1,873/year across 7 years
Top 7% in TX for internal medicine
43
Companies
573
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,286 (86.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,720 (13.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$102 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,907
2023
$2,484
2022
$2,174
2021
$1,227
2020
$1,120
2019
$973
2018
$1,222

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$2,710
AstraZeneca Pharmaceuticals LP
$1,852
Regeneron Healthcare Solutions, Inc.
$1,753
GlaxoSmithKline, LLC.
$1,280
Takeda Pharmaceuticals U.S.A., Inc.
$966
Novartis Pharmaceuticals Corporation
$447
kaleo, Inc.
$434
Octapharma USA, Inc.
$369
Genentech USA, Inc.
$364
CSL Behring
$326
Shire North American Group Inc
$251
ALK-Abello, Inc
$244
BioCryst US Sales Co., LLC
$243
Jubilant HollisterStier LLC
$225
Amgen Inc.
$224
PFIZER INC.
$172
Pharming Healthcare, Inc.
$170
ABBVIE INC.
$110
Kaleo, Inc.
$99
Hikma Pharmaceuticals USA
$81
LEO Pharma Inc.
$80
Grifols USA, LLC
$79
Teva Pharmaceuticals USA, Inc.
$72
SANOFI-AVENTIS U.S. LLC
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Optinose US, Inc.
$43
Greer Laboratories, Inc.
$42
OptiNose US, Inc.
$39
Incyte Corporation
$37
Kedrion Biopharma, Inc.
$37
Phadia US Inc.
$36
BioCryst Pharmaceuticals, Inc.
$34
Sanofi Pasteur Inc.
$25
Lilly USA, LLC
$22
AbbVie Inc.
$21
Blueprint Medicines Corporation
$18
Aimmune Therapeutics, Inc.
$18
ADMA BioManufacturing LLC
$17
Aytu BioPharma, Inc.
$15
HOSPIRA, INC.
$15
Circassia Pharmaceuticals Inc
$12
Cycle Pharmaceuticals Inc
$9
Electromed, Inc.
$6
Top 3 companies account for 48.2% of total payments
Associated products mentioned in payments ›
ADBRY · AIRSUPRA · ANORO · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · Albuked · Auvi-Q · BREO · BREZTRI · CIBINQO · CINRYZE · CUTAQUIG · CUVITRU · DERMATITIS - DISEASE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EOHILIA · EUCRISA · FASENRA · Grastek · Haegarda · Hizentra · ImmunoCAP · Karbinal · NO PRODUCT DISCUSSED · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORALAIR · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · PRE-PEN · RINVOQ · RUCONEST · Ragwitek · Ryaltris · SMARTVEST · SPIRIVA RESPIMAT · SYMBICORT · Sajazir · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in TX.

Equivalent to $118 per 100 Medicare services performed
Looking for a internal medicine in Austin?
Compare internal medicines in the Austin area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
849
Per 100K population
64.9
County median income
$97,169
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER- AUSTIN
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hollander is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 7%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hollander experienced with inclisiran injection (leqvio) for cholesterol?
Based on Medicare claims data, Dr. Hollander performed 5,396 inclisiran injection (leqvio) for cholesterol services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hollander receive payments from pharmaceutical companies?
Yes. Dr. Hollander received a total of $13,108 from 43 companies across 573 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hollander's costs compare to other internal medicines in Austin?
Dr. Hollander's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hollander) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →